Is FBRX undervalued or overvalued?
As of 2025-03-16, the Intrinsic Value of Forte Biosciences Inc (FBRX) is -26.76 USD. This FBRX valuation is based on the model Peter Lynch Fair Value. With the current market price of 5.80 USD, the upside of Forte Biosciences Inc is -561.32%. This means that FBRX is overvalued by 561.32%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
Range | Selected | Upside | |
a | |||
Fair Value | -26.76 - -26.76 | -26.76 | -561.32% |
P/E | (114.73) - (164.18) | (143.95) | -2581.9% |
DDM - Stable | (34.86) - (105.11) | (69.98) | -1306.6% |
DDM - Multi | (28.96) - (69.66) | (41.10) | -808.6% |
Market Cap (mil) | 37.06 |
Beta | 2.70 |
Outstanding shares (mil) | 6.39 |
Enterprise Value (mil) | 20.70 |
Market risk premium | 4.60% |
Cost of Equity | 11.66% |
Cost of Debt | 5.00% |
WACC | 7.67% |